ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕

Email

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

Facebook

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

Tag Archive for: SLAS Boston 2026

EB425_Cover

Europe pays to lose its spin-outs

LATEST NEWS

Constellation® is a mobile robotic ecosystem for scalable cell therapy manufacturing

Cellular Origins Ltd

Cellular Origins secures major CGT funding breakthr...

Winning teams of the product award at SLAS Europe 2024 in Barcelona

SLAS announces finalists for the 2026 Ignite Award

Melt & Marble AB

Melt&Marble secures €7.3m Series A to scale...

ADVERTISEMENT

MAGAZINE

1 / 4

EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

2 / 4

01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

3 / 4

EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

4 / 4

EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

SPONSORED PUBLICATION

Target_Validation_Hood (Neue Größe 1)

Oncology Research

Tiny Models, Big Impact

Organoids are reshaping cancer R&D by providing more accurate, patient-relevant models than classical methods. By bridging the gap between preclinical and early clinical stages, they enable patient-centric … more ➔

newsletter_link

© BIOCOM Interrelations GmbH

Link to LinkedIn
Link to Instagram

Contact
Imprint
Privacy policy